big-gastrin and Breast-Neoplasms

big-gastrin has been researched along with Breast-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for big-gastrin and Breast-Neoplasms

Article	Year
Plasma hPG BMC cancer, 2023, Apr-04, Volume: 23, Issue:1 Recurrence and metastases are still frequent outcomes after initial tumour control in women diagnosed with breast cancer. Although therapies are selected based on tumour characteristics measured at baseline, prognostic biomarkers can identify those at risk of poor outcomes. Circulating progastrin or hPG. Women with incident breast cancers from Calgary, Alberta, Canada enrolled in the Breast to Bone (B2B) study between 2010 to 2016 and provided blood samples prior to any treatment initiation. Plasma from these baseline samples were analysed for circulating progastrin or hPG. hPG Topics: Alberta; Biomarkers; Breast Neoplasms; Female; Humans; Middle Aged; Prognosis	2023

Article

Year

BMC cancer, 2023, Apr-04, Volume: 23, Issue:1

Recurrence and metastases are still frequent outcomes after initial tumour control in women diagnosed with breast cancer. Although therapies are selected based on tumour characteristics measured at baseline, prognostic biomarkers can identify those at risk of poor outcomes. Circulating progastrin or hPG. Women with incident breast cancers from Calgary, Alberta, Canada enrolled in the Breast to Bone (B2B) study between 2010 to 2016 and provided blood samples prior to any treatment initiation. Plasma from these baseline samples were analysed for circulating progastrin or hPG. hPG

Topics: Alberta; Biomarkers; Breast Neoplasms; Female; Humans; Middle Aged; Prognosis

2023